Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | GGACT | Human | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of GGACT mRNA | CTD | PMID:24763279 | GGACT | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Ggact (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GGACT mRNA | CTD | PMID:36331819 | GGACT | Human | 1,1-dichloroethene | decreases expression | ISO | Ggact (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of GGACT mRNA | CTD | PMID:26682919 | GGACT | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Ggact (Rattus norvegicus) | 6480464 | [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in increased expression of GGACT mRNA | CTD | PMID:27840820 | GGACT | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Ggact (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | GGACT | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Ggact (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | GGACT | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ggact (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GGACT mRNA | CTD | PMID:21570461 | GGACT | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GGACT mRNA | CTD | PMID:28628672 | GGACT | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Ggact (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GGACT mRNA | CTD | PMID:36041667 | GGACT | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Ggact (Mus musculus) | 6480464 | Fenretinide results in increased expression of GGACT mRNA | CTD | PMID:28973697 | GGACT | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of GGACT mRNA | CTD | PMID:24780913 | GGACT | Human | amitrole | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of GGACT mRNA | CTD | PMID:38685447 | GGACT | Human | amphetamine | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of GGACT mRNA | CTD | PMID:30779732 | GGACT | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of GGACT gene | CTD | PMID:25304211 | GGACT | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGACT mRNA | CTD | PMID:32525701 | GGACT | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGACT mRNA | CTD | PMID:32525701 | GGACT | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of GGACT gene | CTD | PMID:25304211 | GGACT | Human | arsenite(3-) | increases expression | ISO | Ggact (Mus musculus) | 6480464 | arsenite results in increased expression of GGACT protein | CTD | PMID:37955338 | GGACT | Human | avobenzone | decreases expression | EXP | | 6480464 | avobenzone results in decreased expression of GGACT mRNA | CTD | PMID:31016361 | GGACT | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of GGACT mRNA | CTD | PMID:32234424 | GGACT | Human | bisphenol A | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of GGACT mRNA | CTD | PMID:25181051 | GGACT | Human | bisphenol A | multiple interactions | ISO | Ggact (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GGACT mRNA and [bisphenol A co-treated with tributyltin] results in decreased expression of GGACT mRNA | CTD | PMID:31129395 and PMID:36041667 | GGACT | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GGACT mRNA | CTD | PMID:28628672 | GGACT | Human | bisphenol F | multiple interactions | ISO | Ggact (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GGACT mRNA | CTD | PMID:36041667 | GGACT | Human | cobalt dichloride | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of GGACT mRNA | CTD | PMID:24386269 | GGACT | Human | cyclosporin A | decreases expression | ISO | Ggact (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of GGACT mRNA | CTD | PMID:19770486 | GGACT | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GGACT mRNA | CTD | PMID:28628672 | GGACT | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of GGACT mRNA | CTD | PMID:37042841 | GGACT | Human | gentamycin | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of GGACT mRNA | CTD | PMID:33387578 | GGACT | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GGACT mRNA | CTD | PMID:28628672 | GGACT | Human | iron dichloride | decreases expression | EXP | | 6480464 | ferrous chloride results in decreased expression of GGACT mRNA | CTD | PMID:35984750 | GGACT | Human | ketamine | increases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Ketamine results in increased expression of GGACT mRNA | CTD | PMID:20080153 | GGACT | Human | methimazole | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of GGACT mRNA | CTD | PMID:38685447 | GGACT | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of GGACT mRNA | CTD | PMID:28001369 | GGACT | Human | paracetamol | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of GGACT mRNA | CTD | PMID:33387578 | GGACT | Human | PCB138 | multiple interactions | ISO | Ggact (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | GGACT | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ggact (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GGACT mRNA | CTD | PMID:36331819 | GGACT | Human | phenobarbital | affects expression | ISO | Ggact (Mus musculus) | 6480464 | Phenobarbital affects the expression of GGACT mRNA | CTD | PMID:23091169 | GGACT | Human | pirinixic acid | decreases expression | ISO | Ggact (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of GGACT mRNA | CTD | PMID:17426115 and PMID:23811191 | GGACT | Human | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Ggact (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of GGACT mRNA | CTD | PMID:28903501 | GGACT | Human | propiconazole | decreases expression | ISO | Ggact (Mus musculus) | 6480464 | propiconazole results in decreased expression of GGACT mRNA | CTD | PMID:21278054 | GGACT | Human | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGACT mRNA | CTD | PMID:32525701 | GGACT | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of GGACT mRNA | CTD | PMID:38568856 | GGACT | Human | sodium arsenite | decreases expression | ISO | Ggact (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of GGACT mRNA | CTD | PMID:37682722 | GGACT | Human | tetrachloromethane | decreases expression | ISO | Ggact (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of GGACT mRNA | CTD | PMID:27339419 and PMID:31919559 | GGACT | Human | thioacetamide | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of GGACT mRNA | CTD | PMID:34492290 | GGACT | Human | tributylstannane | multiple interactions | ISO | Ggact (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of GGACT mRNA | CTD | PMID:31129395 | GGACT | Human | trichloroethene | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of GGACT mRNA | CTD | PMID:33387578 | GGACT | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of GGACT mRNA | CTD | PMID:37042841 | GGACT | Human | triticonazole | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | triticonazole results in decreased expression of GGACT mRNA | CTD | PMID:36084822 | GGACT | Human | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of GGACT mRNA | CTD | PMID:29453283 | GGACT | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of GGACT gene | CTD | PMID:29154799 | GGACT | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of GGACT mRNA | CTD | PMID:28001369 and PMID:29154799 | GGACT | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of GGACT mRNA | CTD | PMID:25979313 | GGACT | Human | vinclozolin | decreases expression | ISO | Ggact (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of GGACT mRNA | CTD | PMID:23034163 | |